Diamyd Replaces CEO
Diamyd Medical AB announces that Elisabeth Lindner today has left her position as President and CEO of the Company. Excecutive Vice President Peter Zerhouni has been appointed Acting President and CEO.Elisabeth Lindner has left her position as President and CEO due to disagreement with the Board concerning certain important matters. Peter Zerhouni has been involved in all aspects of the Company since 2006, including a key role in driving the Company's business and clinical trials forward. Zerhouni has a combined financial and biotechnology background, and studied at Lund University in